Avoro Capital Advisors LLC reports

Company location: New York, NY
Fiscal year end: 31 December

Avoro Capital Advisors LLC has filed 312 SEC EDGAR filings since 13 Feb 2015

Filter by type:
SC13D
SC13G

SEC filing history

Showing 76-100 of 312 matching filings.

Per page

25

Current page

4

SC 13G/A

APELLIS PHARMACEUTICALS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

AMICUS THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MADRIGAL PHARMACEUTICALS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MERSANA THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

PMV PHARMACEUTICALS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ASCENDIS PHARMA A/S

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KYMERA THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MONTE ROSA THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MIRATI THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

XENON PHARMACEUTICALS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

VERRICA PHARMACEUTICALS INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

CYMABAY THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SPYRE THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

STRUCTURE THERAPEUTICS INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

UNITED THERAPEUTICS CORPORATION

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MARINUS PHARMACEUTICALS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

BIOCRYST PHARMACEUTICALS INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

IO BIOTECH, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-16573

13F-HR filing

Filing date: 14 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-36500

4 filing

Filing date: 14 Sep 2023
Reporting date: 12 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-16573

13F-HR filing

Filing date: 14 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-38560

FORM 4 SUBMISSION

Filing date: 20 Jun 2023
Reporting date: 15 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-16573

13F-HR filing

Filing date: 15 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

XENON PHARMACEUTICALS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MONTE ROSA THERAPEUTICS, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .